EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY-NC-ND 4.0

Efficacy of probiotics, prebiotics, and synbiotics on liver enzymes, lipid profiles, and inflammation in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials

Youwen Pan, Yafang Yang, Jiale Wu, Haiteng Zhou, Chao Yang

BMC Gastroenterology · 2024

DOI: 10.1186/s12876-024-03356-y ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift BMC Gastroenterology, 2024. Verfasst von Youwen Pan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Nephrology Department, Lai'an County People's Hospital, Chuzhou, 239000, China. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Prebiotics, Probiotics, Synbiotics. Die Arbeit wurde bisher 75-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Jiangnan University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: There is a contradiction in the use of microbiota-therapies, including probiotics, prebiotics, and synbiotics, to improve the condition of patients with nonalcoholic fatty liver disease (NAFLD). The aim of this review was to evaluate the effect of microbiota-therapy on liver injury, inflammation, and lipid levels in individuals with NAFLD. METHODS: Using Pubmed, Embase, Cochrane Library, and Web of Science databases were searched for articles on the use of prebiotic, probiotic, or synbiotic for the treatment of patients with NAFLD up to March 2024. RESULTS: Thirty-four studies involving 12,682 individuals were included. Meta-analysis indicated that probiotic, prebiotic, and synbiotic supplementation significantly improved liver injury (hepatic fibrosis, SMD = -0.31; 95% CI: -0.53, -0.09; aspartate aminotransferase, SMD = -0.35; 95% CI: -0.55, -0.15; alanine aminotransferase, SMD = -0.48; 95% CI: -0.71, -0.25; alkaline phosphatase, SMD = -0.81; 95% CI: -1.55, -0.08), lipid profiles (triglycerides, SMD = -0.22; 95% CI: -0.43, -0.02), and inflammatory factors (high-density lipoprotein, SMD = -0.47; 95% CI: -0.88, -0.06; tumour necrosis factor alpha, SMD = -0.86 95% CI: -1.56, -0.56). CONCLUSION: Overall, supplementation with probiotic, prebiotic, or synbiotic had a positive effect on reducing liver enzymes, lipid profiles, and inflammatory cytokines in patients with NAFLD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Non-alcoholic Fatty Liver DiseasePrebioticsProbioticsSynbioticsHumansAlanine TransaminaseInflammationLipidsLiverRandomized Controlled Trials as Topic

Stichwörter der Autor:innen

Indicators of liver injuryMeta-analysisMicrobiota therapyNonalcoholic fatty liver disease

Substanzen

Alanine TransaminaseLipidsPrebiotics

Autor:innen und Institutionen

  • Nephrology Department, Lai'an County People's Hospital, Chuzhou, 239000, China.
  • Department of Public Health and Preventive Medicine, Wuxi School of Medicine, Jiangnan University, No. 1800, Lihu Avenue, Binhu District, Wuxi, 214000, China.
  • Key Laboratory of Environmental Medicine and Engineering of Ministry of Education, Department of Nutrition and Food Hygiene, School of Public Health, Southeast University, Nanjing, 210009, China.
  • Department of Public Health and Preventive Medicine, Wuxi School of Medicine, Jiangnan University, No. 1800, Lihu Avenue, Binhu District, Wuxi, 214000, China. chaoyang@jiangnan.edu.cn.

Förderung

  • Jiangnan University

Zitieren

APA

Pan, Y., Yang, Y., Wu, J., Zhou, H., & Yang, C. (2024). Efficacy of probiotics, prebiotics, and synbiotics on liver enzymes, lipid profiles, and inflammation in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials. BMC Gastroenterology. https://doi.org/10.1186/s12876-024-03356-y

Vancouver

Pan Y, Yang Y, Wu J, Zhou H, Yang C. Efficacy of probiotics, prebiotics, and synbiotics on liver enzymes, lipid profiles, and inflammation in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials. BMC Gastroenterology. 2024. doi:10.1186/s12876-024-03356-y

BibTeX
@article{Pan2024,
  author = {Pan, Youwen and Yang, Yafang and Wu, Jiale and Zhou, Haiteng and Yang, Chao},
  title = {Efficacy of probiotics, prebiotics, and synbiotics on liver enzymes, lipid profiles, and inflammation in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials},
  journal = {BMC Gastroenterology},
  year = {2024},
  doi = {10.1186/s12876-024-03356-y}
}
Kostenlos starten →